Back to Latest SignalBLOOMBERG TECH / BUSINESS

Flagship’s Afeyan Sees UK Bet Creating Next Moderna

Source: Bloomberg Tech · NOV 16, 2026

Flagship Pioneering founder and CEO Noubar Afeyan says the biotech venture firm hopes its new UK investment can grow to as much as £600 million “relatively soon,” as it establishes its first full-scale company-creation operation outside the US. Speaking on Bloomberg’s “The Pulse With Francine Lacqua”, the Moderna co-founder explains why Flagship chose the UK, how AI could accelerate drug discovery and the creation of new biotech companies, and why governments and industry need agreed safeguards for increasingly autonomous AI agents. (Source: Bloomberg)

Sources

  • Read the original at Bloomberg Tech

Related on Frontier

  • Dan Ives on Nvidia Without Jensen Huang, Microsoft Outage Nov 13, 2026
  • AI Investors Brace for Data Center Restrictions Nov 15, 2026
  • Anthropic IPO Tests Investor Appetite for AI Nov 14, 2026
MORE LATEST SIGNALSIGNALS